BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1612952)

  • 1. [Panhypopituitarism, Diabetes Insipidus and Bone Pain - Is There a Systemic Disease Behind it?].
    Bertschinger M; Sze L; Bosma I; Dommann-Scherrer C; Goede J
    Praxis (Bern 1994); 2024 Jan; 113(1):23-26. PubMed ID: 38381107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hand-Schüller-Christian syndrome combined with empty sella syndrome: A case report and literature review.
    Ji W; Chen X
    Medicine (Baltimore); 2023 Mar; 102(10):e33216. PubMed ID: 36897687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insipid diabetes and vaginal ulcers: evidence for the diagnosis of Langerhans cell hypophysitis.
    Correia S; Silva JD; Rocha G; Oliveira MJ
    Endokrynol Pol; 2022; 73(5):905-906. PubMed ID: 35971941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panhypopituitarism in a patient with a hypothalamic and pineal germ cell tumor.
    Puchalski A; Elias H
    Endocrinol Diabetes Metab Case Rep; 2022 Mar; 2022():. PubMed ID: 35266452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Langerhans' cell histiocytosis and diabetes insipidus in a young smoker.
    Earlam K; Souza CA; Glikstein R; Gomes MM; Pakhale S
    Can Respir J; 2015 Sep; ():. PubMed ID: 26331444
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.
    Arima H; Cheetham T; Christ-Crain M; Cooper D; Drummond J; Gurnell M; Levy M; McCormack A; Newell-Price J; Verbalis JG; Wass J
    Clin Endocrinol (Oxf); 2022 Aug; ():. PubMed ID: 36030512
    [No Abstract]   [Full Text] [Related]  

  • 7. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis.
    Lian H; Cui L; Yang Y; Wei A; Cheng H; Li N; Zhang L; Ma H; Zhao X; Wang T; Li Z; Zhang R
    Pituitary; 2022 Feb; 25(1):108-115. PubMed ID: 34302575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China.
    Ji X; Wang Z; Wang W; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Endocrinol (Lausanne); 2020; 11():76. PubMed ID: 32153511
    [No Abstract]   [Full Text] [Related]  

  • 9. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.
    Haupt R; Minkov M; Astigarraga I; Schäfer E; Nanduri V; Jubran R; Egeler RM; Janka G; Micic D; Rodriguez-Galindo C; Van Gool S; Visser J; Weitzman S; Donadieu J;
    Pediatr Blood Cancer; 2013 Feb; 60(2):175-84. PubMed ID: 23109216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.
    Shioda Y; Adachi S; Imashuku S; Kudo K; Imamura T; Morimoto A
    Int J Hematol; 2011 Dec; 94(6):545-51. PubMed ID: 22139588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis.
    Imashuku S; Kudo N; Kaneda S; Kuroda H; Shiwa T; Hiraiwa T; Inagaki A; Morimoto A
    Int J Hematol; 2011 Dec; 94(6):556-60. PubMed ID: 22015494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Langerhans cell histiocytosis of the infundibulum presenting with fulminant diabetes insipidus.
    Horn EM; Coons SW; Spetzler RF; Rekate HL
    Childs Nerv Syst; 2006 May; 22(5):542-4. PubMed ID: 16456689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine aspects of Langerhans cell histiocytosis.
    Soliman AT; Alsalmi I; Banna NE; Asfour M
    Indian J Pediatr; 1996; 63(3):402-6. PubMed ID: 10830020
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment options--commentary.
    Arceci RJ
    Br J Cancer Suppl; 1994 Sep; 23():S58-60. PubMed ID: 8075010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis.
    Minehan KJ; Chen MG; Zimmerman D; Su JQ; Colby TV; Shaw EG
    Int J Radiat Oncol Biol Phys; 1992; 23(3):519-24. PubMed ID: 1612952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?
    Rosenzweig KE; Arceci RJ; Tarbell NJ
    Med Pediatr Oncol; 1997 Jul; 29(1):36-40. PubMed ID: 9142204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis.
    Maghnie M; Aricò M; Villa A; Genovese E; Beluffi G; Severi F
    AJNR Am J Neuroradiol; 1992; 13(5):1365-71. PubMed ID: 1414829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
    Dunger DB; Broadbent V; Yeoman E; Seckl JR; Lightman SL; Grant DB; Pritchard J
    N Engl J Med; 1989 Oct; 321(17):1157-62. PubMed ID: 2797079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
    Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.